✦ LIBER ✦

The usefulness of the EQ-5D in differentiating among persons with major depressive episode and anxiety

✍ Scribed by Alison L. Supina; Jeffrey A. Johnson; Scott B. Patten; Jeanne V. A. Williams; Colleen J. Maxwell

Publisher: Springer Netherlands
Year: 2007
Tongue: English
Weight: 382 KB
Volume: 16
Category: Article
ISSN: 0962-9343
DOI: 10.1007/s11136-006-9159-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Putting the ‘Q’ in depression QALYs: a c

Putting the ‘Q’ in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures

✍ Rachel Mann; Simon Gilbody; David Richards 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 289 KB

Health-related quality of life using EQ-

✍ Laila Mahmoud Matalqah; Khaldoon Mahmoud Radaideh; Zuraidah Mohd Yusoff; Ahmed A 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 150 KB

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial